Clinical Trial Update: Study Of Sunitinib In Combination With Docetaxel Vs Docetaxel In Patients With Advanced Breast Cancer [Phase 3]

View source ↗

Summary

A phase 3 trial comparing sunitinib plus docetaxel versus docetaxel alone in patients with advanced breast cancer has completed, with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Sutent (sunitinib)
• Taxotere (docetaxel)

Snippet

Sponsor: Pfizer | Conditions: Breast Neoplasms | Phase 3 | Status: COMPLETED | Results posted: 2011-02-28